Skip to main content
. 2020 Sep 24;38(3):339–345. doi: 10.1093/fampra/cmaa102

Table 1.

Sociodemographic and clinical characteristics for cohort study participants (TFES and control combined) and the test–retest subjects recruited from the TFES

Cohort study participants Test–retest subjectsc
Baselinea Completion of 12–24-month follow-upb
Total (N = 360) Yes (n = 285) No (n = 75) P-value Total (N = 60)
Gender (%, n) N = 360 N = 285 N = 75 0.544 N = 60
 Female 70.8% (255) 71.6% (204) 68.0% (51) 71.7% (43)
 Male 29.2% (105) 28.4% (81) 32.0% (24) 28.3% (17)
Age (mean ± SE), year 41.9 (0.4) 41.9 (0.4) 41.8 (0.8) 0.931 48.2 (1.0)
Marital status (%, n) N = 360 N = 285 N = 75 0.543 N = 60
 Married 18.9% (68) 18.3% (52) 78.7% (59) 80.0% (48)
 Unmarried 81.1% (292) 81.8% (233) 21.3% (16) 20.0% (12)
Employment status (%, n) N = 329 N = 279 N = 50 0.379 N = 54
 Working 47.7% (157) 48.8% (136) 42.0% (21) 70.4% (38)
 Not working 52.3% (172) 51.3% (143) 58.0% (29) 29.6% (16)
Chronic diseases (%, n) N = 360 N = 285 N = 75 N = 60
 No chronic disease 70.8% (255) 74.4% (212) 57.3% (43) 68.3% (41)
 One or more chronic diseases 29.2% (105) 25.6% (73) 42.7% (32) 31.7% (19)
Household income N = 360 N = 45
Median $13 000 $16 000
 Above population median 46.1% (166) 51.1% (23)
 Below population median 53.9% (194) 48.9% (22)

SE, standard error.

aBaseline data collection period: TFES group (January 2012–September 2014); control group (January 2014–December 2016).

bFollow-up data collection period: TFES group (August 2013–March 2016); control group (September 2014–May 2017).

cTest–retest data collection dates: December 2019–January 2020.